Thyroid cancer is the most common endocrine malignancy with almost one million people
living with thyroid cancer in the United States. Although early-stage well-differentiated …

Background Questions exist regarding patient selection for surgery in anaplastic thyroid
carcinoma (ATC), particularly with the advent of neoadjuvant‐targeted therapeutics. The …

Introduction Advanced papillary thyroid cancer (PTC) has a poor prognosis, 60~ 70% of
which become radio iodine refractory (RAI-R), but the molecular markers that assess PTC …

Background Locally infiltrating (T4) differentiated thyroid carcinomas (DTC) represent a
challenge. Surgical strategy and adjuvant therapy should be planned balancing morbidity …

Background Re-operative thyroid surgery (RTS) is performed in patients of differentiated
thyroid cancer (DTC) with residual or recurrent disease. However, there is a paucity of …

Internal jugular vein tumor thrombus is an extremely rare condition in thyroid carcinoma, but
it does exist. Correlated with greater aggressiveness with a higher incidence of distant …

Lenvatinib is a medication that targets multiple tyrosine kinases and is commonly used to
treat various types of cancer. With its frequent usage, monitoring and assessing its potential …

Background: Questions exist regarding patient selection for surgery in anaplastic thyroid
carcinoma (ATC), particularly with the advent of neoadjuvant-targeted therapeutics. The …

Total thyroidectomy with central and lateral neck dissection for poorly differentiated thyroid
carcinoma (with video) Total thyroidectomy with central and lateral neck dissection for poorly …